Human Complement Serum - May 31, 2017

Posted by Leanne Kodsman on

May 31, 2017 Innovative Research's Single Donor Human Complement Serum was recently used in the following study:

Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica

Lukmanee Tradtrantip, Xiaoming Yao, Tao Su, Alex J. Smith, Alan S. Verkman - Acta Neuropathologica, 2017 ... Complement dependent cytotoxicity Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank's buffer, and cells were incubated at 37 °C for specified times. ...

  • Tags: Human Serum, Single Donor Human Complement Serum

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Unlock Your Research Potential with Our Premier E. Coli Competent Cells
    Dive into the world of unparalleled genetic research with our diverse lineup of E. coli...
    Read the Article
    Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
    In the ever-evolving landscape of molecular biology, precision tools are essential for ...
    Read the Article
    Revolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
    In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
    Read the Article

    ← Older Post Newer Post →

    ×